Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record.

Enhanced Susceptibility to Iodide Myxedema in Patients with Hashimoto's Disease

BRAVERMAN, LEWIS E., INGBAR, SIDNEY H., VAGENAKIS, APOSTOLOS G., ADAMS, LEVI, MALOOF, FARAHE·1971·The Journal of Clinical Endocrinology & Metabolism

Abstract

Studies were performed in 6 patients with proven Hashimoto's disease and one patient with probable Hashimoto's disease who were initially euthyroid, as judged from clinical findings, serum thyroxine (T4) and serum TSH concentrations. When these patients were given saturated solution of potassium iodide (5 drops containing approximately 180 mg of iodide daily), 4 of the 7 developed hypothyroidism within 4 to 6 weeks as evidenced by clinical findings, subnormal values for serum T4, and elevated values for serum TSH concentration. Values quickly returned to normal when iodides were withdrawn. In the remaining 3 patients, evidence of hypothyroidism did not develop despite continuation of iodide administration for as long as 17–30 weeks. No obvious differences between the 4 patients who developed iodide myxedema and the 3 who did not were evident in respect to known duration of the disease, size of goiter, initial level of thyroid function or intensity of the auto-immune process as judged by circulating autoantibody titers. The possible similarities between Hashimoto's disease and Graves' disease with respect to the occurrence of enhanced sensitivity to iodide induced myxedema in the 2 disorders is considered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-32-4-515

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 184

Metadata

Authors
BRAVERMAN, L. E., INGBAR, S. H., VAGENAKIS, A. G., ADAMS, L., & MALOOF, F.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1971-04
Volume
32
Issue
4
Pages
515-521
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2102862600
Cited by
184
References
0
FWCI
6.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced Susceptibility to Iodide Myxedema in Patients with Hashimoto's Disease. https://app.cochat.ai/papers/10.1210/jcem-32-4-515
The paper
BRAVERMAN, L. E., INGBAR, S. H., VAGENAKIS, A. G., ADAMS, L., & MALOOF, F. (1971). Enhanced Susceptibility to Iodide Myxedema in Patients with Hashimoto's Disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-32-4-515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.